Resultados de la búsqueda 71-80 of 14404 for B%20cell%20lymphomas

  1. Hematología - Ensayos clínicos - Mayo Clinic

    ... B]. This Phase 3 study is designed to evaluate the specificity and sensitivity of 99mTc-MIP-1404 SPECT/CT imaging to correctly identify subjects with ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B). Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. A Study to Determine How BI 907828 is Taken up in the Tumor and to ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ... B]. This Phase 3 study is designed to evaluate the specificity and sensitivity of 99mTc-MIP-1404 SPECT/CT imaging to correctly identify subjects with ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B). Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. A Study to Determine How BI 907828 is Taken up in the Tumor and to ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    standard surgery (ILND); B. neoadjuvant chemotherapy followed by standard surgery (ILND); or C. neoadjuvant chemoradiotherapy followed by standard surgery ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. A Study of Lutetium Lu 177 Dotatate ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of MK-1026 (formerly ARQ 531) in participants with hematologic malignancies of chronic ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...